Expression, purification, and cytotoxic evaluation of IL24-BR2 fusion protein
Interleukin (IL) 24 is a pro-inflammatory and tumor suppressor cytokine capable of inducing selective apoptosis in various cancer cells. BR2, on the other hand, is an anti-microbial peptide with selective penetrability to the cancer cells. In this study, we aimed to produce and purify a fusion prote...
Main Authors: | Marjan Pourhadi, Fahimeh Jamalzade, Ali Jahanian-Najafabadi, Fatemeh Shafiee |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Research in Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2019;volume=14;issue=4;spage=320;epage=328;aulast=Pourhadi |
Similar Items
-
In silico design of two novel fusion proteins, p28-IL-24 and p28-M4, targeted to breast cancer cells
by: Reza Ghavimi, et al.
Published: (2020-01-01) -
Optimization of the Expression of DT386-BR2 Fusion Protein in Escherichia coli using Response Surface Methodology
by: Fatemeh Shafiee, et al.
Published: (2017-01-01) -
IL-24: A new player in the pathogenesis of pro-inflammatory and allergic skin diseases
by: Yasutaka Mitamura, et al.
Published: (2020-07-01) -
Interleucina 25 na interface materno-fetal em camundongos.
by: Aline Carvalho
Published: (2016) -
Interleucina 25 na interface materno-fetal em camundongos.
by: Carvalho, Aline
Published: (2016)